W. Perry Gordon

1.8k total citations
37 papers, 960 citations indexed

About

W. Perry Gordon is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, W. Perry Gordon has authored 37 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in W. Perry Gordon's work include Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Carcinogens and Genotoxicity Assessment (6 papers). W. Perry Gordon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Carcinogens and Genotoxicity Assessment (6 papers). W. Perry Gordon collaborates with scholars based in United States, Norway and Vietnam. W. Perry Gordon's co-authors include Sidney D. Nelson, Albert W. Rettenmeier, Thomas A. Baillie, Erik Dybing, K S Prickett, R H Lévy, Randolph J. McMurtry, Robert H. McClanahan, Erik J. Søderlund and Jørn A. Holme and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

W. Perry Gordon

36 papers receiving 906 citations

Peers

W. Perry Gordon

PHARM

PPCH

PMH

Surendra K. Puri United States

J. Paul Phillips United States

M. Hümpel Germany

Judith L. Engel United States

Sonal P. Sanghani United States

Maria Konstandi Greece

M. Delaforge France

Samson Symchowicz United States

Alper Okyar Türkiye

Surendra K. Puri United States

W. Perry Gordon

118 ×0.4

PHARM

396 ×1.6

98 ×0.5

PPCH

31 ×0.2

100 ×1.0

PMH

Citations per year, relative to W. Perry Gordon W. Perry Gordon (= 1×) peers Surendra K. Puri

Countries citing papers authored by W. Perry Gordon

Since Specialization

Citations

This map shows the geographic impact of W. Perry Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Perry Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Perry Gordon more than expected).

Fields of papers citing papers by W. Perry Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Perry Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Perry Gordon. The network helps show where W. Perry Gordon may publish in the future.

Co-authorship network of co-authors of W. Perry Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of W. Perry Gordon. A scholar is included among the top collaborators of W. Perry Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Perry Gordon. W. Perry Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Bo, W. Perry Gordon, Wendy Richmond, Todd Groessl, & Tove Tuntland. (2015). Use of solubilizers in preclinical formulations: Effect of Cremophor EL on the pharmacokinetic properties on early discovery compounds. European Journal of Pharmaceutical Sciences. 87. 52–57. 17 indexed citations

Iyer, Radhika, Nanxin Li, Valentina Molteni, et al.. (2014). TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. Cancer Chemotherapy and Pharmacology. 75(1). 131–141. 31 indexed citations

Richmond, Wendy, et al.. (2010). Interstrain Differences of In Vitro Metabolic Stability and Impact on Early Drug Discovery. Journal of Pharmaceutical Sciences. 99(11). 4463–4468. 15 indexed citations

Liu, Bo, Jonathan Chang, W. Perry Gordon, et al.. (2007). Snapshot PK: a rapid rodent in vivo preclinical screening approach. Drug Discovery Today. 13(7-8). 360–367. 43 indexed citations

Cheng, Haiyung, et al.. (1992). Disposition of 8‐Methyl‐8‐azabicyclo[3,2,1]octan‐3‐yl 3,5‐Dichlorobenzoate, a Potent 5‐Hydroxytryptamine Antagonist, and Two Metabolites in Dogs and Monkeys. Journal of Pharmaceutical Sciences. 81(4). 345–347. 1 indexed citations

Gordon, W. Perry, et al.. (1992). Identification of urinary metabolites of 8-methyl-8-azabicyclo- 3,2,1] octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey.. Drug Metabolism and Disposition. 20(4). 596–602. 1 indexed citations

Rettenmeier, Albert W., William N. Howald, René H. Levy, et al.. (1989). Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry. 18(3). 192–199. 41 indexed citations

Rettenmeier, Albert W., et al.. (1987). Studies on the metabolic fate of valproic acid in the rat using stable isotope techniques. Xenobiotica. 17(10). 1147–1157. 17 indexed citations

Gordon, W. Perry, et al.. (1987). The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.. Drug Metabolism and Disposition. 15(5). 589–594. 77 indexed citations

10.

Rettenmeier, Albert W., W. Perry Gordon, K S Prickett, et al.. (1986). Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.. Drug Metabolism and Disposition. 14(4). 443–453. 39 indexed citations

11.

Rettenmeier, Albert W., W. Perry Gordon, K S Prickett, R H Lévy, & Thomas A. Baillie. (1986). Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.. Drug Metabolism and Disposition. 14(4). 454–464. 29 indexed citations

12.

Nelson, Sidney D., et al.. (1984). Activation mechanism of Tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein. Biochemical and Biophysical Research Communications. 121(1). 213–219. 20 indexed citations

13.

Patel, J. M., et al.. (1983). Comparison of hepatic biotransformation and toxicity of allyl alcohol and [1,1-2H2]allyl alcohol in rats.. Drug Metabolism and Disposition. 11(2). 164–166. 25 indexed citations

14.

Huitric, Alain C., W. Perry Gordon, & Sidney D. Nelson. (1982). Preparation of (+)- and (-)-2,3-dibromo-1-propanol. Journal of Chemical & Engineering Data. 27(4). 474–475.

15.

Lynn, R K, J.E. Bauer, W. Perry Gordon, et al.. (1979). Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.. Drug Metabolism and Disposition. 7(3). 138–144. 14 indexed citations

16.

Swanson, B N, W. Perry Gordon, R K Lynn, & Kate Gerber. (1978). Seminal excretion, vaginal absorption, distribution and whole blood kinetics of d-methadone in the rabbit.. Journal of Pharmacology and Experimental Therapeutics. 206(2). 507–514. 15 indexed citations

17.

Lynn, R K, et al.. (1977). New gas chromatographic assay for the quantification of methadone. Journal of Chromatography A. 131. 329–340. 14 indexed citations

18.

Lynn, R K, et al.. (1976). The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations.. Drug Metabolism and Disposition. 4(5). 504–509. 14 indexed citations

19.

Igarashi, M., Bobby R. Alford, Yousuke Nakai, & W. Perry Gordon. (1972). Behavioral Auditory Function After Transection of Crossed Olivo-Cochlear Bundle in the Cat: I. Pure-tone Threshold and Perceptual Signal-to-noise Ratio. Acta Oto-Laryngologica. 73(2-6). 455–466. 37 indexed citations

20.

Albright, J.L., et al.. (1966). Behavioral Responses of Cows to Auditory Training. Journal of Dairy Science. 49(1). 104–106. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact